相关实验视频

Updated: Jul 6, 2026

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

评估交叉保护:脑膜炎球菌疫苗在预防淋病方面显示出有效性 - - 一项系统性审查和元分析

I Szondy¹, K Lőrincz¹, A Walter²

¹Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine, Semmelweis University, Mária utca 41, 1085 Budapest, Hungary; Centre for Translational Medicine, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary.

|May 7, 2025

概括

外膜囊泡 (OMV) 疫苗,包括4CMenB,在预防淋病方面表现出适度的有效性,特别是在与男性发生性关系的男性 (MSM) 等高风险群体中. 建议完成完整的疫苗接种系列,以获得对这种性传播感染的最佳保护.

科学领域:

传染性疾病传染性疾病
疫苗学疫苗学疫苗学
公共卫生公共卫生

背景情况:

淋病是一个重要的全球健康问题,不成比例地影响与男性发生性关系的男性 (MSM).
外膜囊泡 (OMV) 脑膜炎球菌疫苗,特别是4CMenB,显示出对淋病的交叉保护潜力.

研究的目的:

系统地审查和分析OMV疫苗在预防淋病方面的有效性.
评估疫苗接种情况 (完全或部分) 对淋病发病率的影响.

主要方法:

在PubMed,Embase和CENTRAL数据库进行系统搜索,截至2024年7月.
包括研究OMV疫苗接种者淋病发病率的原始文章.
随机效应元分析以估计聚合疫苗有效性 (VE),使用ROBINS-I和ROB-2工具进行偏差风险评估.

主要成果:

对7项研究的综合分析 (6项追溯,1项前性) 显示,总体VE为38% (95%CI:22%-50%).
4CMenB疫苗的VE值为41% (OR=0.59;95%CI:0.46-0.76).该疫苗的VE值为41% (OR=0.59;95%CI:0.46-0.76).该疫苗的VE值为41% (OR=0.59;95%CI:0.46-0.76).
完全疫苗接种提供了比部分疫苗接种更大的潜在保护 (24%的增加),尽管具有很高的异质性 (I2=86%). 疫苗接种后的2-3年内,VE下降了.

结论:

OMV疫苗对淋病提供中等程度的保护.
建议4CMenB疫苗用于性活跃的人,优先进行完整的疫苗接种系列.
应考虑将4CMenB向高风险MSM群体进行向治疗,以预防淋病.

关键词:

淋病 Gonorrhoea 这是一种淋病.脑膜炎球菌疫苗脑膜炎球菌疫苗预防预防预防系统性审查系统性审查这是一个元分析.

更多相关视频

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

相关概念视频

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Cryptococcal Meningitis

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...